Quercetin

Critical Reviews in Food Science and Nutrition

Volumn 39, Issue 3, 1999, Pages 236-244

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0006761022     PISSN: 10408398     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (60)

1. Agullo G, Gamet L, Besson C, Demigné C, Rémésy C. Quercetin exerts a preferential cytotoxic effect on active dividing colon carcinoma TH29 and Caco-2 cells. Cancer Lett 1994; 87: 55-63.
2. Aravindakshan M, Chauhan PS, Sundaram K. Studies on germinal effects of quercetin, a naturally occurring flavonoid. Mutat Res 1985; 144: 99-106.
3. Avila MA, Velasco JA, Cansado J, Notario V. Quercetin mediates the down-regulation of mutant p53 in the human breast cancer cell line MDA-MB468. Cancer Res 1994; 54: 2424-2428.
4. Bokkenheuser VD, Scholes JV, Klinger MM, Winter J. Natural anticarcinogens. Arch Chir Scand Suppl 1991; 562: 71-76.
5. Canada AT, Watkins WD, Nguyen TD. The toxicity of flavonoids to guinea pig enterocytes. Toxicol Appl Pharmacol 1989; 99: 357-361.
6. Carver JH, Carrano AV, MacGregor JT, Genetic effects of the flavonols quercetin, kaempferol, and galangin on Chinese hamster ovary cells in vitro. Mutat Res 1983; 113: 45-60.
7. Conquer JA, Maiani G, Azzini E, Raguzzini A, Holub BJ. Supplementation with quercetin markedly increases plasma quercetin concentration without effect on selected risk factors for heart disease in healthy subjects. J Nutr 1998; 128: 593-597.
8. Crebelli R, Aquilina G, Falcone E, Carere A. Urinary and faecal mutagenicity in Sprague-Dawley rats dosed with the food mutagens qucrcetin and rutin. Food Chem Toxicol 1987; 25: 9-15.
9. Cross HJ, Tilby M, Chipman JK, Ferry DR, Gescher A. Effect of quercetin on the genotoxic potential of cisplatin. Int J Cancer 1996; 66: 404-408.
10. Czeczot H, Tudek B, Kusztelak J, Szymzyk T, Dobrowolska B, et al. Isolation and studies of the mutagenic activity in the Ames test of flavonoids naturally occurring in medical herbs. Mutat Res 1990; 240: 209-216.
11. Dragsted LO, Strube M, Leth T. Dietary levels of plant phenols and other non-nutritive components: Could they prevent cancer? Eur J Cancer Prev 1997; 6: 522-528.
12. Dunnick JK, Hailey JR. Toxicity and carcinogenicity studies of quercetin, a natural component of foods. Fundam Appl Toxicol 1992; 19: 423-431.
13. Elia G, Santoro MG. Regulation of heat shock protein synthesis by quercetin in human erythroleukaemia cells. Biochem J 1994; 300: 201-209.
14. Ferry DR, Smith A, Malkhandi J, Fyfe DW, deTakats PG, Anderson D, et al. Phase I clinical trial of the flavonoid quercetin: Pharmacokinetics and evidence for in vivo tyrosine kinase inhibition. Clin Cancer Res 1996; 2: 659-668.
15. Formica JV, Regelson W. Review of the biology of quercetin and related flavonoids. Food Chem Tox 1995; 33: 1061-1080.
16. Fukushima S, Hagiwara A, Ogiso T, Shibata M, Ito N. Promoting effects of various chemicals in rat urinary bladder carcinogenesis initiated by N-nitroso-n-butyl-(4-hydroxybutyl)amine. Food Chem Toxicol 1983; 21: 59-68.
17. Gaspar J, Laires A, Monteiro M, Laurcano O, Ramos E, Rueff J. Quercetin and the mutagenicity of wines. Mutagenesis 1993; 8: 51-55.
18. Gross M, Pfeiffer M, Martini M, Campbell D, Slavin J, Potter J. The quantitation of metabolites of quercetin flavonols in human urine. Cancer Epidemiol Biomarkers Prev 1996; 5: 711-720.
19. Gugler R, Leschik M, Dengler HJ. Disposition of quercetin in man after single oral and intravenous doses. Eur J Pharmacol 1975; 9: 229-234.
20. Herrmann K. Flavonols and flavones in food plants: a review. J Food Technol 1976; 11: 433-448.
21. Hertog MGL, Feskens EJM, Hollman PCH, Katan MB, Kromhout D. Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study. Lancet 1993a; 342: 1007-1011.
22. Hertog MG, Hollman PC, Katan MB, Kromhout D. Intake of potentially anticarcinogenic flavonoids and their determinants in adults in the Netherlands. Nutr Cancer 1993b; 20: 21-29.
23. Hertog MGL, Katan MB. Quercetin in foods, cardiovascular disease and cancer. In Rice-Evans CA, Packer L, ed. Flavonoids in Health and Disease. New York: Marcel Dekker. 1998; 447-467.
24. Hirono I, Ueno I, Hosaka S, Takanashi H, Matsushima T, et al. Carcinogenicity examination of quercetin and rutin in ACI rats. Cancer Lett 1981; 13: 15-21.
25. Hollman PCH, de Vries JHM, van Leeuwen SD, Mengelers MJB, Katan MB. Absorption of dietary quercetin glycosides and quercetin in healthy ileostomy volunteers. Am J Clin Nutr 1995; 62: 1276-1282.
26. Hollman PCH, Gaag MVD, Mengelers MJB, van Trijp JMP, de Vries JHM, Katan MB. Absorption and disposition kinetics of the dietary antioxidant quercetin in man. Free Rad Biol Med 1996; 21: 703-707.
27. Hollman PCH, Katan MB. Absorption, metabolism and bioavailability of flavonoids. In Rice-Evans CA, Packer L, ed. Flavonoids in Health and Disease. New York: Marcel Dekker. 1998; 483-522.
28. IARC Monographs. Quercetin. 1983; 31: 213-229.
29. Ito N, Hagiwara A, Tamano S, Kagawa M, Shibata M, et al. Lack of carcinogenicity of quercetin in F344/DuCrj rats. Jpn J Cancer Res 1989; 80: 317-325.
30. Janssen K, Mensink RP, Cox FJ, Harryvan JL, Hovenier R et al. Effects of the flavonoids quercetin and apigenin on hemostasis in healthy volunteers: results from an in vitro and a dietary supplement study. Am J Clin Nutr 1998; 67: 255-262.
31. Kato K, Mori H, Fujii M, Bunai Y, Nishikawa A, et al. Lack of promotive effect of quercetin on methylazoxymethanol acetate carcinogenesis in rats. J Toxicol Sci 1984; 9: 319-325.
32. Knekt P, Jarvinen R, Reunanen A, Maatela J. Flavonoid intake and coronary mortality in Finland: a cohort study. Br Med J 1996; 312: 478-481.
33. Kuhnau J. The flavonoids. A class of semi-essential food components: Their role in human nutrition. World Rev Nutr Diet 1976; 24: 117-191.
34. Larocca LM, Giustacchini M, Maggiano N, Ranelletti FO, Piantelli M, et al. Growth-inhibitory effect of quercetin and presence of type II estrogen binding sites in primary human transitional cell carcinomas. J Urology 1994; 152: 1029-1033.
35. Larocca LM, Teofili L, Sica S, Piantelli M, Maggiano N, et al. Quercetin inhibits the growth of leukemic progenitors and induces the expression of transforming growth factor-β1 in these cells. Blood 1995; 85: 3654-3661.
36. Manach C, Morand C, Texier O, Favier M-L, Agullo G, Demigné C, et al. Quercetin metabolites in plasma of rats fed diets containing rutin or quercetin. J Nutr 1995; 125: 1911-1922.
37. Manach C, Regerat F, Texier O, Agullo G, Demigne C, Remesy C. Bioavailability, metabolism and physiological impact of 4-oxo-flavonoids. Nutr Res 1996; 16: 517-544.
38. Middleton E, Jr., Drzewiecki G, Krishnarao D. Quercetin: An inhibitor of antigen-induced human basophil histamine release. J Immunol 1981; 127: 546-550.
39. Middleton E Jr., Kandaswami C. The impact of plant flavonoids on mammalian biology: implications for immunity, inflammation and cancer. In: J.B. Harborne, Ed. The Flavonoids: Advances in Research Since 1986. London: Chapman & Hall. 1993; 619-652.
40. Morino K, Matsukara N, Kawachi T, Ohgaki H, Sugimura T, Hirono I. Carcinogenicity test of quercetin and rutin in golden hamsters by oral administration. Carcinogenesis 1982; 3: 93-97.
41. NTP Technical Report on the toxicology and carcinogenesis of quercetin in F344/N rats. NIH Publication No. 91-3140. USDHHS, PHS, Research Triangle Park, North Carolina, USA, 1992.
42. Otsuka H, Inaba M, Fujikura T, Kunitomo M. Histochemical and functional characteristics of metachromatic cells in the nasal epithelium in allergic rhinitis: Studies of nasal scrapings and their dispersed cells. J Allergy Clin Immunol 1995; 96: 528-536.
43. Pace-Asciak CR, Hahn S, Diamandis EP, Soleas G, Goldberg DM. The red wine phenolics trans-resveratrol and quercetin block human platelet aggregation and eicosanoid synthesis: Implications for protection against coronary heart disease. Clin Chim Acta 1995; 235: 207-219.
44. Pamukcu AM, Yalciner S, Hatcher JF, Bryan GT. Quercetin, a rat intestinal and bladder carcinogen present in bracken fern (Pteridium aquilinum). Cancer Res 1980; 40: 3468-3472.
45. Piantelli M, Maggiano N, Ricci R, Larocca LM, Capelli A, et al. Tamoxifen and quercetin interact with type II estrogen binding sites and inhibit the growth of human melanoma cells. J Invest Dermatol 1995; 105: 248-253.
46. Pradja N, Singhal RL, Yeh YA, Olah E, Look KY, Weber G. Linkage of reduction in 1-phosphatidylinositol 4-kinase activity and inositol 1,4,5-trisphosphate concentration in human ovarian carcinoma cells treated with quencetin. Life Sci 1995; 56: 1587-1593.
47. Rastogi PB, Levin RE. Induction of sperm abnormalities in mice by quercetin. Environ Mutagen 1987; 9: 79-86.
48. Rice-Evans CA, Packer L, Ed. Flavonoids in Health and Disease. New York: Marcel Dekker. 1998.
49. Sato H, Takahashi M, Furukawa F, Miyakawa Y, Hasegawa R. Initiating potential of 2-(2-furyl)-3-(5-nitro-2-furyl)acrylamide (AF-2), butylated hydroxyanisole (BHA), butylated hydroxytoluene (BHT) and 3,3′,4′,5,7-pentahydroxyflavone (quercetin) in two-stage mouse skin carcinogenesis. Cancer Lett 1987; 38: 49-56.
50. Scambia G, Ranelletti FO, Panici PB, DeVincenzo R, Bonanno G, et al. Quercetin potentiates the effect of Adriamycin in a multidrug-resistant MCF-7 human breast-cancer cell line: P-glycoprotein as a possible target. Cancer Chemother Pharmacol 1994; 34: 459-464.
51. Singhal RL, Yeh YA, Prajda N, Olah E, Sledge GW, Jr., Weber G. Quercetin down-regulates signal transduction in human breast carcinoma cells. Biochem Biophys Res Comm 1995; 208: 425-431.
52. Starvic B. Quercetin in our diet: From potent mutagen to probable anticarcinogen. Clin Biochem 1994; 27: 245-248.
53. Stoewsand GS, Anderson JL, Boyd JN, Hrazdina G, Babish JG, et al. Quercetin: A mutagen, not a carcinogen, in Fischer rats. J Toxicol Environ Health 1984; 14: 105-114.
54. Uddin Sh, Choudhry MA. Quercetin, a bioflavonoid, inhibits the DNA synthesis of human leukemia cells. Biochem Mol Biol Int 1995; 36: 545-550.
55. 14C] quercetin in the ACI rat. Jpn J Exp Med 1982; 53:41-50.
56. Walle T, Eaton EA, Walle UK. Quercetin, a potent and specific inhibitor of the human P-form phenolsulfotransferase. Biochem Pharmacol 1995; 50: 731-734.
57. Wei Y-Q, Zhao X, Kariya Y, Fukata H, Teshigawara K, Uchida A. Induction of apoptosis by quercetin: Involvement of heat shock protein. Canc Res 1994; 54: 4952-4957.
58. Willhite CC. Teratogenic potential of quercetin in the rat. Food Chem Toxicol 1982; 20: 75-79.
59. Yeh YA, Herenyiova M, Weber G. Quercetin: Synergistic action with carboxyamidotriazole in human breast carcinoma cells. Life Sci 1995; 57: 1285-1292.
60. Zhu BT, Liehr JG. Quercetin increases the severity of estradiol-induced tumorigenesis in hamster kidney. Toxicol Appl Pharmacol 1994; 125: 149-158.